Your immune cells are some of the hungriest cells in your body, and when they go to war they burn energy like sprinting muscle. That single fact explains why creatine, a compound most people associate with the weight room, keeps showing up in immunology journals.
Here is the short version before we go deep. Immune cells take up creatine and appear to use it as an energy buffer, and a series of striking mouse studies from UCLA found that creatine supports the tumor fighting activity of T cells and dendritic cells. At the same time, other laboratory work suggests creatine can dial down certain immune sensors, and in mouse models of allergic asthma it made airway inflammation worse, not better. In humans, a 2026 systematic review concluded that creatine supplementation does not significantly reduce inflammatory biomarkers overall. So the honest summary of creatine and the immune system is this: the biology is real and fascinating, the animal data cut in both directions, and the human evidence is thin. Nobody should be taking creatine to treat or prevent any disease, and this article will not tell you to.
What creatine clearly has going for it is an unusually deep safety record at normal doses, which we will get to, along with what the studies actually used and what remains genuinely unknown.
Why Immune Cells Want Creatine in the First Place
Creatine’s job in the body is energy logistics. Cells store it as phosphocreatine, a reservoir that can regenerate ATP, the molecule that powers nearly everything a cell does, faster than any other system. About 95 percent of the body’s creatine sits in skeletal muscle, which is why the sports science literature dwarfs everything else.
But muscle is not the only tissue with sudden energy demands. When an immune cell detects a threat, it has to divide rapidly, migrate to the site of trouble, pump out signaling molecules called cytokines, and in some cases physically destroy other cells. All of that is expensive. A 2021 review in Nutrients, The Role of Creatine in the Development and Activation of Immune Responses, walks through the evidence that immune cells express the creatine transporter, a protein called SLC6A8 that pulls creatine into cells, and that creatine availability shapes how these cells behave.
That last part matters. Most cells cannot make meaningful amounts of creatine themselves. They depend on the transporter to import it from the blood, which is what makes supplementation biologically plausible in the first place. Whether that plausibility translates into anything a healthy person would notice is a separate question, and the answer so far is: nobody has properly tested it.
The Cancer Immunology Work, and Why It Gets Quoted So Much
The most cited creatine and immunity research comes from Lili Yang’s laboratory at UCLA. In 2019, her team published a study in the Journal of Experimental Medicine which, per the university’s own summary of the T cell findings, was the first to show that creatine uptake is critical to the antitumor activity of CD8 T cells, the immune system’s killer cells. The work was done in mice. Tumor infiltrating T cells ramped up their expression of the creatine transporter, mice lacking the transporter fought tumors poorly, and creatine supplementation improved the effectiveness of existing immunotherapies in those mouse models.
In June 2026 the same group extended the story to dendritic cells, the sentinel cells that capture tumor fragments and instruct killer T cells where to attack. According to UCLA’s report on the dendritic cell study, published in iScience, dendritic cells inside tumors increased their creatine intake and depended on it to function in that nutrient starved environment. Dendritic cells engineered to lack the transporter survived poorly and primed T cells weakly. Daily creatine injections in mouse models of melanoma slowed tumor growth and increased both the number and activation of tumor infiltrating dendritic cells, and the researchers traced the effect to higher ATP levels sustaining inflammatory signaling.
This is genuinely elegant science, and I think it deserves the attention it gets. But three details routinely go missing when it gets repackaged into supplement marketing. First, these are mouse studies plus human cells in a dish; no human trial has tested creatine as an addition to cancer immunotherapy. Second, the melanoma work used daily creatine injections, not oral powder in a shaker bottle. Third, a 2021 review of creatine in T cell antitumor immunity by the same group is candid that creatine regulation outside muscle and brain remains largely elusive, which is scientist speak for early days.
There is also a genuinely inconvenient wrinkle. A 2024 review of creatine metabolism in cancer biology points out that while creatine can enhance antitumor CD8 T cell activity, other studies have shown creatine metabolism can supply energy to cancer cells themselves and support their growth and migration in certain contexts. The same molecule, feeding both armies. Anyone telling you this story with only one side is not reading the literature. It is a topic for oncology researchers, not supplement decisions.
The Other Direction: Creatine Can Also Quiet Immune Sensors
Here is the part of the creatine and immune system story that almost never makes it into articles like this one, and it is exactly why this site exists.
Laboratory work going back more than a decade found that creatine, creatinine and creatine ethyl ester can reduce the expression of Toll like receptors on macrophages. Toll like receptors are the danger sensors of the innate immune system, the proteins that recognize the molecular fingerprints of bacteria and viruses and sound the alarm. In cell culture, creatine dialed down several of them, including TLR2, TLR3, TLR4 and TLR7. The authors of the Nutrients 2021 review, who did some of this work, put the implication plainly: these in vitro studies raise the possibility that creatine supplementation might decrease the host’s ability to detect infections. Related animal work found that creatine pretreatment reduced pathologic inflammation in a rat lung transplant model, which is helpful if you are a transplanted lung facing reperfusion injury and less obviously helpful if you want your immune system on high alert.
Two things keep me from overreacting to this. It is cell culture and small animal work, several steps removed from a person taking 5 g a day. And crucially, the enormous human safety literature on creatine, which we will get to below, has not surfaced a signal of increased infections in supplement users across hundreds of trials. If daily creatine meaningfully suppressed immune defense in humans, thirty years of heavy use by athletes would probably have hinted at it.
But the honest framing is that nobody has run the study. I could not find a single randomized human trial testing whether creatine supplementation changes infection rates, respiratory illness days, or vaccine responses in healthy people. That trial design exists and gets run for vitamin D, probiotics and colostrum in athletes all the time. For creatine, the question is simply open. When a company implies its creatine product “supports immune health,” it is leaning on mouse T cells while ignoring mouse asthma, and on neither occasion citing a human outcome.
The Asthma Finding That Deserves More Attention
Speaking of mouse asthma. In 2007, Brazilian researchers published a study in the American Journal of Respiratory Cell and Molecular Biology showing that creatine supplementation exacerbated allergic lung inflammation and airway remodeling in mice. Mice sensitized to ovalbumin, a standard way of modeling allergic asthma, were given creatine at 0.5 g per kg per day. The supplemented, sensitized mice showed more airway hyperresponsiveness, more eosinophilic inflammation, more of the allergy driving cytokines interleukin 4 and interleukin 5, thicker airway smooth muscle and more collagen in the airway walls. The authors noted the finding was the opposite of what they expected, and they raised it precisely because asthma is common among athletes who take creatine.
Follow up work by an overlapping group in 2019 replicated the pattern in a different mouse strain and started to explain it, finding that creatine worsened experimental asthma through purinergic signaling involving the P2X7 receptor, with creatine triggering ATP and cytokine release from human airway cells and immune cells in vitro. Interestingly, a related study found that adding low intensity aerobic exercise largely canceled the creatine driven exacerbation in mice.
What does this mean for a person with asthma? Honestly, we do not know. These are mouse models at a dose far above human use per kilogram, and human trials of creatine in athletes have not reported asthma flares as a side effect pattern. But it is a real, replicated preclinical signal pointing in the uncomfortable direction, published by researchers with no product to sell. If you have significant allergic asthma and you are considering creatine, this is squarely a conversation for your doctor, and any article on creatine and immunity that skips it is doing you a disservice.
What Human Studies Actually Show About Inflammation
The human evidence on creatine and immune related outcomes is almost entirely about inflammation markers around hard exercise, and it is a story of a few striking early results followed by a sobering synthesis.
The classic finding: in 2004, researchers supplemented experienced marathon runners with 20 g of creatine per day for 5 days before a 30 km race. In the 30 km race study, runners in the placebo condition showed large post race rises in markers of muscle damage and inflammation, including a 2.34 fold rise in tumor necrosis factor alpha and a 6.6 fold rise in prostaglandin E2. Creatine blunted the tumor necrosis factor alpha rise by about 34 percent and the prostaglandin E2 rise by about 61 percent, and abolished the rise in lactate dehydrogenase. A similar protocol before a half ironman produced comparable reductions in proinflammatory cytokines after the race.
Then the null results arrived. Twelve weeks of creatine supplementation produced no change in C reactive protein, interleukin 1 beta, interleukin 6 or tumor necrosis factor alpha in people with mild to moderate knee osteoarthritis, a population with genuine chronic low grade inflammation. And in 2026, a systematic review of creatine and inflammation registered on PROSPERO pulled the human trials together and concluded that creatine supplementation does not significantly reduce inflammatory biomarkers in humans based on current evidence, while acknowledging that some benefit appeared under intense endurance conditions and that results are inconsistent across populations.
That is about as clean an example as you will find of why single studies should not set your expectations. Creatine may modestly buffer the acute inflammatory spike of extreme endurance exercise, in trained men, at loading doses, around races. As a general anti inflammatory strategy for regular people, the evidence says no, or at least not yet, and this site is not going to pretend otherwise.
The Gut Brain Axis Result Worth Knowing About
Now the newest and, for a site about creatine and the brain, most interesting thread. In 2026, a group publishing in Cell Metabolism reported something unexpected about how creatine gets from your gut to your brain at all. Studying depression in mice and in human samples, they found that gut bacteria help regulate creatine absorption through the gut brain axis. Specifically, acetate produced by Bifidobacterium switched on the creatine transporter gene Slc6a8 in intestinal cells through histone acetylation, a chemical modification that changes how genes are read. More transporter meant more creatine absorbed and more reaching the brain, and in their mouse models this eased depressive like behaviors. The paper also describes a clinical study pairing Bifidobacterium with creatine as a candidate therapeutic strategy, and the authors themselves list several limitations.
I want to be careful here, because this is exactly the kind of study that gets inflated. It does not show that creatine treats depression, and neither this article nor any supplement should suggest that; depression is a medical condition and its treatment belongs with clinicians. What makes the paper genuinely important is more basic. It suggests that how much creatine you absorb, and possibly how much reaches your brain, is not fixed. It may depend partly on the state of your gut microbiome, because bacterial metabolites appear to tune the expression of the very transporter that moves creatine across the gut wall. If that mechanism holds up in independent human work, it could help explain why creatine studies keep finding such variable responses between individuals, which is one of the field’s most persistent annoyances.
It also connects two literatures that rarely talk to each other. The microbiota gut brain axis field has spent a decade mapping how gut bacteria influence the brain through metabolites, immune signaling and the vagus nerve, mostly in preclinical models. Creatine research has spent thirty years on muscle and, more recently, the brain’s energy supply. A creatine dependent link between them, running through bacterial acetate and a transporter gene, is the kind of finding that will either be replicated into a big deal or quietly fail to reproduce. As of this writing it is one impressive paper plus a small clinical component, and that is the weight it should carry.
Safety: What 685 Trials and the Adverse Event Databases Say
Whatever you make of the immunology, safety is where creatine’s evidence base is genuinely deep, and it is worth being specific because the internet is full of recycled myths.
In 2025, researchers at Texas A&M published a set of analyses in the Journal of the International Society of Sports Nutrition. One paper evaluated side effects reported across 685 human clinical trials of creatine supplementation, alongside worldwide adverse event report databases and even a social media sentiment analysis. The consistent picture across individual studies is that creatine monohydrate is well tolerated and not associated with clinically significant side effects, with anecdotal complaints persisting mainly on social media rather than in trial data. A companion paper analyzing adverse event reports in international surveillance systems reached the same place. The most commonly reported nuisance in trials is mild gastrointestinal discomfort, typically at high loading doses taken all at once.
Two honesty notes, because they matter on this site. First, the leading authors of these safety papers are established creatine researchers, and the publication fees for that journal issue were funded by a creatine manufacturer as part of a conference special issue; the authors state the funder had no role in the analyses. That does not invalidate 685 trials, but you deserve to know it. Second, regulators outside the US have looked hard at creatine too. Spain’s food safety agency AESAN published a 2024 risk assessment of creatine containing food supplements, noting that EU law already permits an exercise performance claim for foods providing 3 g of creatine daily, which tells you where European regulators see the evidence as solid: physical performance, not immunity and not cognition.
On that last point, the EU’s food safety authority EFSA reviewed 21 human intervention studies in 2024 for a proposed cognitive function claim at 3 g per day and rejected it, finding that effects seen at short term high doses around 20 g per day did not persist at lower continuous doses. That ruling binds product claims in the EU, not the US, but the underlying evidence review applies everywhere, and it is a useful calibration for anyone assuming creatine’s brain and immune stories are further along than they are.
The kidney myth deserves its one paragraph. Creatine breaks down into creatinine, the very molecule doctors measure to estimate kidney function, so supplementation can nudge that lab number without any actual change in kidney health. Controlled studies in healthy people have repeatedly failed to find kidney damage at standard doses. People with existing kidney disease are a different matter entirely and should not take creatine without medical supervision. If you have any kidney concern, talk to your doctor before starting, and tell them you supplement so they can interpret your bloodwork correctly.
Dosage: What the Studies Actually Used
Because this article has toured everything from mouse melanoma to marathon runners, it is worth laying the doses side by side, since blurring them is how bad supplement advice gets made.
The body’s daily creatine turnover is roughly 2 to 4 g, met by a mix of diet, mainly meat and fish, and synthesis in the liver, kidneys and pancreas. The standard human supplement protocols are 3 to 5 g of creatine monohydrate per day taken continuously, or a short loading phase of about 20 g per day split into four doses for 5 to 7 days followed by 3 to 5 g daily. The inflammation studies in endurance athletes used the 20 g loading protocol for 5 days before races. EU regulation recognizes 3 g per day for the physical performance claim.
The immune findings mostly used something else entirely. The mouse asthma studies used 0.5 g per kg per day, which scaled naively to an 80 kg human would be 40 g daily, and mice are not small humans anyway. The UCLA melanoma work used daily injections, bypassing the gut. The Toll like receptor work used cells in dishes. None of these doses or routes tells you what 5 g of powder in water does to a human immune system, and any product page that stitches them together is hoping you will not check.
For the brain specifically, the research picture suggests brain creatine is harder to raise than muscle creatine, and studies that moved brain measures often used higher doses, in the range of 10 to 20 g per day, for weeks. That is a topic we cover in depth elsewhere on this site; the short version is that dose response in the brain is an open research question, not a settled fact.
If you do choose to take creatine for the reasons the evidence actually supports, plain creatine monohydrate at 3 to 5 g per day is the form and dose with the overwhelming majority of the safety and efficacy data behind it. Fancier forms exist and cost more; independent evidence that they outperform monohydrate does not, at least not yet.
A practical note on timing and consistency, since readers always ask. Creatine works by saturating tissue stores over days to weeks, not by producing an acute effect after one serving, so the time of day matters far less than simply taking it daily. Taking it with a meal may modestly help uptake and tends to be gentler on the stomach than a large dose in plain water on an empty gut. If loading doses cause digestive grumbling, splitting them into smaller servings across the day, or skipping the loading phase entirely and accepting a slower ramp to saturation over three to four weeks, solves the problem for most people in the trial literature. None of this changes anything about the immune questions in this article; it is simply how the compound has been used in the studies that established its safety.
Who These Findings Apply To, and Who They Do Not
A quick map, because population matters more in this literature than almost anywhere else. The cancer immunology results apply to mice with tumors and to human cells in laboratory conditions. The airway inflammation results apply to allergen sensitized mice. The acute inflammation blunting applies to trained endurance athletes doing races at loading doses, and even there the 2026 systematic review urges caution. The safety data apply broadly to healthy adults across hundreds of trials, which is the one genuinely generalizable finding in this article. The gut brain axis mechanism was worked out largely in mice, with a preliminary clinical component.
Missing from every list: healthy adults taking normal doses and measuring immune outcomes that matter, like infections. If you take creatine and you have not been sick this winter, that is an anecdote, and this site does not traffic in those, including our own.
What Would Change the Picture
Three studies would move this from intriguing to actionable. A randomized trial of creatine supplementation with infection incidence or vaccine response as the outcome in healthy adults, which has never been done. A human trial of creatine alongside cancer immunotherapy, which the UCLA group’s work openly invites and which oncologists, not supplement users, should run. And independent replication of the Bifidobacterium and creatine transporter mechanism in humans, which would tell us whether gut health genuinely gates how much creatine reaches the brain.
Until then, here is where I land on creatine and the immune system. The energetics are real: immune cells import creatine and use it. The preclinical findings are genuinely mixed, with tumor fighting cells strengthened in some models and allergic airway inflammation worsened in others, and the sensor dampening work sits unresolved in between. The human inflammation data net out to no overall effect. And the safety record at 3 to 5 g per day is about as good as it gets in the supplement world. That combination, promising biology, contradictory animal data, absent human outcomes, is what “early” looks like, and pretending otherwise would make us exactly the kind of site we built this one to be an alternative to.